Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1
Vieira, Carlos A⋅Agarwal, Avinash⋅Book, Benita K⋅Sidner, Richard A⋅Bearden, Christopher M⋅Gebel, Howard M⋅Roggero, Anthony L⋅Fineberg, Naomi S⋅Taber, Timothy⋅Kraus, Michael A and Pescovitz, Mark D
Transplantation, vol. 77, (no. 4), pp. 548, 2004-02-00. | Journal Article